medvisМедицинская визуализацияMedical Visualization1607-07632408-9516RDS-Media Ltd.10.24835/1607-0763-2019-3-82-106medvis-797Research ArticleМАЛЫЙ ТАЗSMALL PELVISМагнитно-резонансная томография как основа современного подхода в диагностике и оценке эффекта лечения рака шейки матки (обзор литературы)Magnetic-resonance imaging as a basis for a modern approach in diagnostics and treatment evaluation of cervical cancer (literature review)ПетроваА. С.PetrovaA. S.

врач-рентгенолог отделения лучевой диагностики

197758, п. Песочный, Ленинградская область, Ленинградская ул., д. 68

Тел.: +7-921-339-02-33

radiologist at the Department of Radiology

197758, Russian Federation, St. Petersburg, Pesochny, Leningradskaya str., 68

Phone: +7-921-339-02-33

a.petrova.05@gmail.comСмирноваО. А.SmirnovaO. A.

врач-онколог хирургического онкогинекологического отделения

197758, п. Песочный, Ленинградская область, Ленинградская ул., д. 68

oncologist of the surgical oncological and gynecological department

197758, Russian Federation, St. Petersburg, Pesochny, Leningradskaya str., 68

МищенкоА. В.MishchenkoA. V.

врач-онколог хирургического онкогинекологического отделения, профессор НК и ОЦ

197758, п. Песочный, Ленинградская область, Ленинградская ул., д. 68

doct. of med. sci., Head of the Department of Diagnostic and Interventional radiology; Professor of the Scientific Clinical 

197758, Russian Federation, St. Petersburg, Pesochny, Leningradskaya str., 68

БерлевИ. В.BerlevI. V.

доктор мед. наук, заведующий хирургическим онкогинекологическим отделением, ведущий научный сотрудник хирургического онкогинекологического отделения

197758, п. Песочный, Ленинградская область, Ленинградская ул., д. 68

doct. of med. sci.,Head of the surgical oncological and gynecological department, Leading researcher of the surgical oncologicaland gynecological department

197758, Russian Federation, St. Petersburg, Pesochny, Leningradskaya str., 68

УльрихЕ. А.UlrichE. A.

доктор мед. наук, профессор кафедры онкологии; врач-онколог отделения онкогинекологии

197758, п. Песочный, Ленинградская область, Ленинградская ул., д. 68

doct. of med. sci., Professor of oncological department;oncologist of the surgical oncological and gynecological department

197758, Russian Federation, St. Petersburg, Pesochny, Leningradskaya str., 68

МкртчянГ. Б.MkrtchyanH. B.

врач-онколог, аспирант хирургического онкогинекологического отделения

197758, п. Песочный, Ленинградская область, Ленинградская ул., д. 68

PhD-student of the surgical oncological and gynecological department

197758, Russian Federation, St. Petersburg, Pesochny, Leningradskaya str., 68

КосичкинаА. Б.KosichkinaA. B.

врач-рентгенолог отделения лучевой диагностики

197758, п. Песочный, Ленинградская область, Ленинградская ул., д. 68

radiologist at the Department of radiology

197758, Russian Federation, St. Petersburg, Pesochny, Leningradskaya str., 68

НюганенА. О.NyuganenA. O.

врач отделения патоморфологии

197758, п. Песочный, Ленинградская область, Ленинградская ул., д. 68

pathologist at the Department of pathomorphology

197758, Russian Federation, St. Petersburg, Pesochny, Leningradskaya str., 68

Национальный медицинский исследовательский центр онкологии имени Н.Н. ПетроваРоссияN.N. Petrov National Medical Research Oncology Center, Ministry of Health of RussiaRussian FederationНациональный медицинский исследовательский центр онкологии имени Н.Н. Петрова, Санкт-Петербургский государственный университетРоссияN.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia, St Petersburg UniversityRussian FederationНациональный медицинский исследовательский центр онкологии имени Н.Н. Петрова, ФГБОУ ВО “СЗГМУ имени И.И. Мечникова” Минздрава РоссииРоссияN.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia, North-Western State Medical University named after I.I. MechnikovRussian Federation2019030920190382106Copyright © Петрова А.С., Смирнова О.А., Мищенко А.В., Берлев И.В., Ульрих Е.А., Мкртчян Г.Б., Косичкина А.Б., Нюганен А.О., 20192019Петрова А.С., Смирнова О.А., Мищенко А.В., Берлев И.В., Ульрих Е.А., Мкртчян Г.Б., Косичкина А.Б., Нюганен А.О.Petrova A.S., Smirnova O.A., Mishchenko A.V., Berlev I.V., Ulrich E.A., Mkrtchyan H.B., Kosichkina A.B., Nyuganen A.O.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medvis.rdsmedia.ru/jour/article/view/797

В статье рассматриваются современные достижения лучевой диагностики при обследовании пациентов с предполагаемым и верифицированным раком шейки матки (РШМ). Подробно описываются возможности магнитно-резонансной томографии в первичной диагностике заболевания и оценке эффекта проведенного неоадъювантного лечения, обсуждаются условия и оптимальная методика проведения исследования, а также принципы интерпретации полученных данных. Рассмотрены основные прогностические факторы при РШМ, а также приведен краткий обзор существующих методов лечения на различных стадиях заболевания. 

The article discusses the current principles of diagnostic radiology in theevaluation of suspected and verified cervical cancer (CC). Possibilities of magnetic resonance imaging in the primary diagnosis of the disease and effect evaluation of neoadjuvant treatment are described.Conditions and optimal MR-technique, as well asprinciples of data interpretation are discussed. The main prognostic factors for CC are consideredand, also, a brief review of treatment methods for various diseases stages is given.

рак шейки маткидиагностикаоценка распространенностинеоадъювантное лечениемагнитно-резонансная томографияпрогностические факторыхирургическое лечениеcervical cancerdiagnosticsdisease extent assessmentneoadjuvant treatmentmagnetic resonance imagingprognostic factorssurgical treatmentReferencesGLOBOCAN 2018. Estimated cancer incidence, mortality and prevalence worldwide in 2012. [cited12 Sept 2018]. URL: http://gco.iarc.frGLOBOCAN 2018. Estimated cancer incidence, mortality and prevalence worldwide in 2012. [cited12 Sept 2018]. URL: http://gco.iarc.frКаприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2017 году М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2018. 236 с.Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2017 году М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2018. 236 с.In situ cervical carcinoma incidence statistics URL: https://www.cancerresearchuk.org/health-professional/cancerstatistics/statistics-by-cancer-type/cervical-cancer/incidence-in-situ?_ga=2.135120753.116604086.1551041700-535305463.1543059799In situ cervical carcinoma incidence statistics URL: https://www.cancerresearchuk.org/health-professional/cancerstatistics/statistics-by-cancer-type/cervical-cancer/incidence-in-situ?_ga=2.135120753.116604086.1551041700-535305463.1543059799Barchuk A., Bespalov A., Huhtalac H., Chimedd T., Laricheva I., Belyaev A., Brayd F., Anttila A., Auvinen A. Breast and cervical cancer incidence and mortality trends in Russia 1980–2013. Cancer Epidemiol. 2018; 55: 73–80. https://doi.org/10.1016/j.canep.2018.05.008.Barchuk A., Bespalov A., Huhtalac H., Chimedd T., Laricheva I., Belyaev A., Brayd F., Anttila A., Auvinen A. Breast and cervical cancer incidence and mortality trends in Russia 1980–2013. Cancer Epidemiol. 2018; 55: 73–80. https://doi.org/10.1016/j.canep.2018.05.008.International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int. J. Cancer. 2007; 120 (4): 885.International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int. J. Cancer. 2007; 120 (4): 885.Downey K., Riches S.F., Morgan A.V., Giles S., Attygalle A.D., Ind T.E.J., Barton D., Shepherd J.H , Desouza N.M. Relationship between imaging biomarkers of stage I cervical cancer and poor prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. Am. J. Roentgenol. 2013; 200 (2): 314–320. https://doi.org/10.2214/AJR.12.9545.Downey K., Riches S.F., Morgan A.V., Giles S., Attygalle A.D., Ind T.E.J., Barton D., Shepherd J.H , Desouza N.M. Relationship between imaging biomarkers of stage I cervical cancer and poor prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. Am. J. Roentgenol. 2013; 200 (2): 314–320. https://doi.org/10.2214/AJR.12.9545.Follen M., Levenback C.F., Iyer R.B., Grigsby P.W., Boss E.A., Delpassand E.S., Fornage B.D., Fishman E.K. Imaging in cervical cancer. Cancer. 2003; 98 (9): 2028–2038.Follen M., Levenback C.F., Iyer R.B., Grigsby P.W., Boss E.A., Delpassand E.S., Fornage B.D., Fishman E.K. Imaging in cervical cancer. Cancer. 2003; 98 (9): 2028–2038.Bourgioti C., Chatoupis K., Moulopoulos L.A. Current imaging strategies for the evaluation of uterine cervical cancer. Wld J. Radiol. 2016; 8 (4): 342–354. https://doi.org/10.4329/wjr.v8.i4.342.Bourgioti C., Chatoupis K., Moulopoulos L.A. Current imaging strategies for the evaluation of uterine cervical cancer. Wld J. Radiol. 2016; 8 (4): 342–354. https://doi.org/10.4329/wjr.v8.i4.342.Рубцова Н.А., Новикова Е.Г., Синицын В.Е. Возможности МРТ в предоперационной оценке местной распространенности рака шейки матки. Радиология-практика. 2012; 3: 51–64.Рубцова Н.А., Новикова Е.Г., Синицын В.Е. Возможности МРТ в предоперационной оценке местной распространенности рака шейки матки. Радиология-практика. 2012; 3: 51–64.Balleyguier C., Sala E., Da Cunha T., Bergman A., Brkljacic B., Danza F., Forstner R., Hamm B., Kubik-Huch R., Lopez C., Manfredi R., McHugo J., Oleaga L., Togashi K., Kinkel K. Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur. Radiol. 2011; 21: 1102–1110. https://doi.org/10.1007/s00330-010-1998-x.Balleyguier C., Sala E., Da Cunha T., Bergman A., Brkljacic B., Danza F., Forstner R., Hamm B., Kubik-Huch R., Lopez C., Manfredi R., McHugo J., Oleaga L., Togashi K., Kinkel K. Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur. Radiol. 2011; 21: 1102–1110. https://doi.org/10.1007/s00330-010-1998-x.Dappa E., Elger T., Hasenburg A., Düber C., Battista M.J., Hötker A.M. The value of advanced MRI techniques in the assessment of cervical cancer: a review. Insights Imaging. 2017; 8: 471–481. https://doi.org/10.1007/s13244-017-0567-0.Dappa E., Elger T., Hasenburg A., Düber C., Battista M.J., Hötker A.M. The value of advanced MRI techniques in the assessment of cervical cancer: a review. Insights Imaging. 2017; 8: 471–481. https://doi.org/10.1007/s13244-017-0567-0.Bleker S.M., Bipat S., Spijkerboer A.M., van der Velden J., Stoker J., Kenter G.G. The negative predictive value of clinical examination with or without anesthesia versus magnetic resonance imaging for parametrial infiltration in cervical cancer stages IB1 to IIA. Int. J. Gynecol. Cancer. 2013; 23:193–198. https://doi.org/10.1097/IGC.0b013e31827a4ad8.Bleker S.M., Bipat S., Spijkerboer A.M., van der Velden J., Stoker J., Kenter G.G. The negative predictive value of clinical examination with or without anesthesia versus magnetic resonance imaging for parametrial infiltration in cervical cancer stages IB1 to IIA. Int. J. Gynecol. Cancer. 2013; 23:193–198. https://doi.org/10.1097/IGC.0b013e31827a4ad8.Dhoot N.M., Kumar V., Shinagare A., Kataki A.C., Barmon D., Bhuyan U. Evaluation of carcinoma cervix using magnetic resonance imaging: correlation with clinical FIGO staging and impact on management. J. Med. Imaging Radiat. Oncol. 2012; 56: 58–65. https://doi.org/10.1111/j.1754-9485.2011.02333.x.Dhoot N.M., Kumar V., Shinagare A., Kataki A.C., Barmon D., Bhuyan U. Evaluation of carcinoma cervix using magnetic resonance imaging: correlation with clinical FIGO staging and impact on management. J. Med. Imaging Radiat. Oncol. 2012; 56: 58–65. https://doi.org/10.1111/j.1754-9485.2011.02333.x.Кудреватых Е.В. Магнитно-резонансная томография в диагностике и оценке результатов комплексного лечения рака шейки матки: Автореф. дис. ... канд. мед. наук. М., 2011. 24 с.Кудреватых Е.В. Магнитно-резонансная томография в диагностике и оценке результатов комплексного лечения рака шейки матки: Автореф. дис. ... канд. мед. наук. М., 2011. 24 с.Bhosale P., Peungjesada S., Devine C., Balachandran A., Iyer R. Role of magnetic resonance imaging as an adjunct to clinical staging in cervical carcinoma. J. Comput. Assist. Tomogr. 2010; 34 (6): 855–864. https://doi.org/10.1097/RCT.0b013e3181ed3090.Bhosale P., Peungjesada S., Devine C., Balachandran A., Iyer R. Role of magnetic resonance imaging as an adjunct to clinical staging in cervical carcinoma. J. Comput. Assist. Tomogr. 2010; 34 (6): 855–864. https://doi.org/10.1097/RCT.0b013e3181ed3090.Sala E., Wakely S., Senior E., Lomas D. MRI of malignant neoplasms of the uterine corpus and cervix. Am. J. Roentgenol. 2007; 188: 1577–1587. https://doi.org/10.2214/AJR.06.1196.Sala E., Wakely S., Senior E., Lomas D. MRI of malignant neoplasms of the uterine corpus and cervix. Am. J. Roentgenol. 2007; 188: 1577–1587. https://doi.org/10.2214/AJR.06.1196.Nicolate V., Carignan L., Bourdon F., Prosmanne O. MR imaging of cervical carcinoma: A practical staging approach. RadioGraphics. 2000; 20: 1539–1549. https://doi.org/10.1148/radiographics.20.6.g00nv111539.Nicolate V., Carignan L., Bourdon F., Prosmanne O. MR imaging of cervical carcinoma: A practical staging approach. RadioGraphics. 2000; 20: 1539–1549. https://doi.org/10.1148/radiographics.20.6.g00nv111539.Sala E., Rockall A.G., Freeman S.J., Mitchell D.G., Reinhold C. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology. 2013; 266: 717–740. https://doi.org/10.1148/radiol.12120315.Sala E., Rockall A.G., Freeman S.J., Mitchell D.G., Reinhold C. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology. 2013; 266: 717–740. https://doi.org/10.1148/radiol.12120315.Sakuragi N., Satoh C., Takeda N., Hareyama H., Takeda M., Yamamoto R., Fujimoto T., Oikawa M., Fujino T., Fujimoto S. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999; 85: 1547–1554.Sakuragi N., Satoh C., Takeda N., Hareyama H., Takeda M., Yamamoto R., Fujimoto T., Oikawa M., Fujino T., Fujimoto S. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999; 85: 1547–1554.Eisenhauera E.A., Therasseb P., Bogaertsc J., Schwartzd L.H., Sargente D., Fordf R., Danceyg J., Arbuckh S., Gwytheri S., Mooneyg M., Rubinsteing L., Shankarg L., Doddg L.,Kaplanj R., Lacombec D., Verweij J. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur. J. Cancer. 2009; 45: 228–247. https://doi.org/10.1016/j.ejca.2008.10.026.Eisenhauera E.A., Therasseb P., Bogaertsc J., Schwartzd L.H., Sargente D., Fordf R., Danceyg J., Arbuckh S., Gwytheri S., Mooneyg M., Rubinsteing L., Shankarg L., Doddg L.,Kaplanj R., Lacombec D., Verweij J. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur. J. Cancer. 2009; 45: 228–247. https://doi.org/10.1016/j.ejca.2008.10.026.Hong K.S., Ju W., Choi H.J., Kim J.K., Kim M.H., Cho K.S. Differential diagnostic performance of magnetic resonance imaging in the detection of lymph node metastases according to the tumor size in early-stage cervical cancer patients. Int. J. Gynecol. Cancer. 2010; 20: 841–846. https://doi.org/10.1111/IGC.0b013e3181db5140.Hong K.S., Ju W., Choi H.J., Kim J.K., Kim M.H., Cho K.S. Differential diagnostic performance of magnetic resonance imaging in the detection of lymph node metastases according to the tumor size in early-stage cervical cancer patients. Int. J. Gynecol. Cancer. 2010; 20: 841–846. https://doi.org/10.1111/IGC.0b013e3181db5140.Shen G., Zhou H., Jia Z., Deng H. Diagnostic performance of diffusion-weighted MRI for detection of pelvic metastatic lymph nodes in patients with cervical cancer: a systematic review and meta-analysis. Br. J. Radiol. 2015; 88 (1052): 20150063. https://doi.org/10.1259/bjr.20150063.Shen G., Zhou H., Jia Z., Deng H. Diagnostic performance of diffusion-weighted MRI for detection of pelvic metastatic lymph nodes in patients with cervical cancer: a systematic review and meta-analysis. Br. J. Radiol. 2015; 88 (1052): 20150063. https://doi.org/10.1259/bjr.20150063.Drieskens O., Stroobants S., Gysen M., Vandenbosch G., Mortelmans L., Vergote I. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer. Gynecol. Obstet. Invest. 2003; 55: 130–134. https://doi.org/10.1159/000071525.Drieskens O., Stroobants S., Gysen M., Vandenbosch G., Mortelmans L., Vergote I. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer. Gynecol. Obstet. Invest. 2003; 55: 130–134. https://doi.org/10.1159/000071525.Singh N., Arif S. Histopathologic parameters of prognosis in cervical cancer – a review. Int. J. Gynecol. Cancer. 2004; 14: 741–750. https://doi.org/10.1111/j.1048-891X.2004.014504.x.Singh N., Arif S. Histopathologic parameters of prognosis in cervical cancer – a review. Int. J. Gynecol. Cancer. 2004; 14: 741–750. https://doi.org/10.1111/j.1048-891X.2004.014504.x.Reagan J.W., Fu Y.S. Histologic types and prognosis of cancers of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 1979; 5: 1015–1020.Reagan J.W., Fu Y.S. Histologic types and prognosis of cancers of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 1979; 5: 1015–1020.Crissman J.D., Budhraja M., Aron B.S. et al. Histopathologic prognostic factors in stage II and III squamous cell carcinoma of the uterine cervix. Int. J. Gynecol. Pathol. 1987; 6: 97–103.Crissman J.D., Budhraja M., Aron B.S. et al. Histopathologic prognostic factors in stage II and III squamous cell carcinoma of the uterine cervix. Int. J. Gynecol. Pathol. 1987; 6: 97–103.Cohen J.G., Kapp D.S., Shin J.Y. et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am. J. Obstet Gynecol. 2010; 203 (347): 341–346. https://doi.org/10.1016/j.ajog.2010.04.019.Cohen J.G., Kapp D.S., Shin J.Y. et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am. J. Obstet Gynecol. 2010; 203 (347): 341–346. https://doi.org/10.1016/j.ajog.2010.04.019.Mangler M., Lanowska M., Kohler C., Vercellino F., Schneider A., Speiser D. Pattern of cancer recurrence in 320 patients after radical vaginal trachelectomy. Int. J. Gynecol Cancer. 2014; 24: 130–134. https://doi.org/10.1097/IGC.0000000000000012.Mangler M., Lanowska M., Kohler C., Vercellino F., Schneider A., Speiser D. Pattern of cancer recurrence in 320 patients after radical vaginal trachelectomy. Int. J. Gynecol Cancer. 2014; 24: 130–134. https://doi.org/10.1097/IGC.0000000000000012.Park J.Y., Lee J.W., Park B.K., Lee Y.Y., Choi C.H., Kim T.J., Bae D.S., Kim B.G., Park J.J., Park S.Y., Kim C.K. Postoperative outcomes of MR-invisible stage IB1 cervical cancer. Am. J. Obstet. Gynecol. 2014; 211: 168. 1–7. https://doi.org/10.1016/j.ajog.2014.02.032.Park J.Y., Lee J.W., Park B.K., Lee Y.Y., Choi C.H., Kim T.J., Bae D.S., Kim B.G., Park J.J., Park S.Y., Kim C.K. Postoperative outcomes of MR-invisible stage IB1 cervical cancer. Am. J. Obstet. Gynecol. 2014; 211: 168. 1–7. https://doi.org/10.1016/j.ajog.2014.02.032.Kamimori T., Sakamoto K., Fujiwara K., Umayahara K., Sugiyama Y., Utsugi K., Takeshima N., Tanaka H., Gomi N., Takizawa K. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging. Int. J. Gynecol. Cancer. 2011; 21: 349–354.Kamimori T., Sakamoto K., Fujiwara K., Umayahara K., Sugiyama Y., Utsugi K., Takeshima N., Tanaka H., Gomi N., Takizawa K. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging. Int. J. Gynecol. Cancer. 2011; 21: 349–354.Bourgioti C., Chatoupis K., Rodolakis A., Antoniou A., Tzavara C., Koutoulidis V., Moulopoulos L.A. Incremental prognostic value of MRI in the staging of early cervical cancer: a prospective study and review of the literature. Clin. Imaging. 2016; 40 (1): 72–78. https://doi.org/10.1016/j.clinimag.2015.09.012.Bourgioti C., Chatoupis K., Rodolakis A., Antoniou A., Tzavara C., Koutoulidis V., Moulopoulos L.A. Incremental prognostic value of MRI in the staging of early cervical cancer: a prospective study and review of the literature. Clin. Imaging. 2016; 40 (1): 72–78. https://doi.org/10.1016/j.clinimag.2015.09.012.Kim S.H., Lee H.J., Kim Y.W. Correlation between tumor size and surveillance of lymph node metastasis for IB and IIA cervical cancer by magnetic resonance images. Eur. J. Radiol. 2012; 81: 1945–1950. https://doi.org/10.1016/j.ejrad.2011.04.053.Kim S.H., Lee H.J., Kim Y.W. Correlation between tumor size and surveillance of lymph node metastasis for IB and IIA cervical cancer by magnetic resonance images. Eur. J. Radiol. 2012; 81: 1945–1950. https://doi.org/10.1016/j.ejrad.2011.04.053.Kang S., Kim Y.S., Choi H.J., Kim M.H., Cho K.S. Additional value of combined evaluation of tumor size with lymph node size in the detection of lymph node metastases in early-stage cervical cancer patients. J. Comput. Assist. Tomogr. 2013; 37: 572–576. https://doi.org/10.1097/RCT.0b013e31828ba718.Kang S., Kim Y.S., Choi H.J., Kim M.H., Cho K.S. Additional value of combined evaluation of tumor size with lymph node size in the detection of lymph node metastases in early-stage cervical cancer patients. J. Comput. Assist. Tomogr. 2013; 37: 572–576. https://doi.org/10.1097/RCT.0b013e31828ba718.Perez C.A., Camel H.M., Askin F., Breaux S. Endometrial extension of carcinoma of the uterine cervix: a prognostic factor that may modify staging. Cancer. 1981; 48: 170–180.Perez C.A., Camel H.M., Askin F., Breaux S. Endometrial extension of carcinoma of the uterine cervix: a prognostic factor that may modify staging. Cancer. 1981; 48: 170–180.Kim H., Kim W., Lee M., Song E., Loh J.J.K. Tumor volume and uterine body invasion assessed by mri for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy. Jpn J. Clin. Oncol. 2007; 37 (11): 858–866. https://doi.org/10.1093/jjco/hym109.Kim H., Kim W., Lee M., Song E., Loh J.J.K. Tumor volume and uterine body invasion assessed by mri for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy. Jpn J. Clin. Oncol. 2007; 37 (11): 858–866. https://doi.org/10.1093/jjco/hym109.Finan M.A., DeCesare S., Fiorica J.V., Chambers R., Hoffman M.S., Kline R.C., Roberts W.S., Cavanagh D. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: dose the new staging system predict morbidity and survival? Gynecol. Oncol. 1996; 62: 139–147. https://doi.org/10.1006/gyno.1996.0206.Finan M.A., DeCesare S., Fiorica J.V., Chambers R., Hoffman M.S., Kline R.C., Roberts W.S., Cavanagh D. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: dose the new staging system predict morbidity and survival? Gynecol. Oncol. 1996; 62: 139–147. https://doi.org/10.1006/gyno.1996.0206.Marchiolé P., Buénerd A., Benchaib M., Nezhat K., Dargent D., Mathevet P. Clinical significance of lymphovascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol. Oncol. 2005; 97 (3): 727–732. https://doi.org/10.1016/j.ygyno.2005.01.004.Marchiolé P., Buénerd A., Benchaib M., Nezhat K., Dargent D., Mathevet P. Clinical significance of lymphovascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol. Oncol. 2005; 97 (3): 727–732. https://doi.org/10.1016/j.ygyno.2005.01.004.Memarzadeh S., Natarajan S., Dandade D.P., Ostrzega N., Saber P.A., Busuttil A., Lentz S.E., Berek J.S. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstet. Gynecol. 2003; 102 (3): 612–619.Memarzadeh S., Natarajan S., Dandade D.P., Ostrzega N., Saber P.A., Busuttil A., Lentz S.E., Berek J.S. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstet. Gynecol. 2003; 102 (3): 612–619.Yang W., Qiang J.W., Tian H.P., Chen B., Wang A.J., Zhao J.G. Minimum apparent diffusion coefficient for predicting lymphovascular invasion in invasive cervical cancer. J. Magn. Reson. Imaging. 2017; 45 (6): 1771–1779. https://doi.org/10.1002/jmri.25542.Yang W., Qiang J.W., Tian H.P., Chen B., Wang A.J., Zhao J.G. Minimum apparent diffusion coefficient for predicting lymphovascular invasion in invasive cervical cancer. J. Magn. Reson. Imaging. 2017; 45 (6): 1771–1779. https://doi.org/10.1002/jmri.25542.Ahlin P.A., Weiss R. Risk management and compliance in pathology and laboratory medicine. Clin. Lab. Med. 2007; 27: 859–873. https://doi.org/10.1016/j.cll.2007.07.005.Ahlin P.A., Weiss R. Risk management and compliance in pathology and laboratory medicine. Clin. Lab. Med. 2007; 27: 859–873. https://doi.org/10.1016/j.cll.2007.07.005.Patel S., Liyanage S.H., Sahdev A., Rockall A.G., Reznek R.H. Imaging of endometrial and cervical cancer. Insights Imaging. 2010; 1: 309–328. https://doi.org/10.1007/s13244-010-0042-7.Patel S., Liyanage S.H., Sahdev A., Rockall A.G., Reznek R.H. Imaging of endometrial and cervical cancer. Insights Imaging. 2010; 1: 309–328. https://doi.org/10.1007/s13244-010-0042-7.Li Z., Li H., Wang S., Dong D., Yin F., Chen A., Wang S., Zhao G., Fang M., Tian J., Wu S., Wang H. MR-based radiomics nomogram of cervical cancer in prediction of the lymph-vascular space invasion preoperatively. J. Magn. Reson. Imaging. 2019; 49 (5): 1420–1426. https://doi.org/10.1002/jmri.26531.Li Z., Li H., Wang S., Dong D., Yin F., Chen A., Wang S., Zhao G., Fang M., Tian J., Wu S., Wang H. MR-based radiomics nomogram of cervical cancer in prediction of the lymph-vascular space invasion preoperatively. J. Magn. Reson. Imaging. 2019; 49 (5): 1420–1426. https://doi.org/10.1002/jmri.26531.Braithwaite A.C., Dale B.M., Boll D.T., Merkle E.M. Shortand midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology. 2009; 250: 459–465. https://doi.org/10.1148/radiol.2502080849.Braithwaite A.C., Dale B.M., Boll D.T., Merkle E.M. Shortand midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology. 2009; 250: 459–465. https://doi.org/10.1148/radiol.2502080849.Rutledge F.N., Mitchell M.F., Munsell M., Bass S., McGuffee V., Atkinson E.N. Youth as a prognostic factor in carcinoma of the cervix: a matched analysis. Gynecol. Oncol. 1992; 44: 123–130.Rutledge F.N., Mitchell M.F., Munsell M., Bass S., McGuffee V., Atkinson E.N. Youth as a prognostic factor in carcinoma of the cervix: a matched analysis. Gynecol. Oncol. 1992; 44: 123–130.Delaloye J.F., Pampallona S., Coucke P.A., De Grandi P. Younger age as a bad prognostic factor in patients with carcinoma of the cervix. Eur. J. Obstet. Gynecol. Reprod. Biol. 1996; 64: 201–205.Delaloye J.F., Pampallona S., Coucke P.A., De Grandi P. Younger age as a bad prognostic factor in patients with carcinoma of the cervix. Eur. J. Obstet. Gynecol. Reprod. Biol. 1996; 64: 201–205.Gui B., Valentini A.L., Miccò M., D'Agostino G.R., Tagliaferri L., Zannoni G.F., Fanfani F., Manfredi R., Bonomo L. Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery. Acta Radiol. 2016; 57 (9): 1123–1131. https://doi.org/10.1177/0284185115617346.Gui B., Valentini A.L., Miccò M., D'Agostino G.R., Tagliaferri L., Zannoni G.F., Fanfani F., Manfredi R., Bonomo L. Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery. Acta Radiol. 2016; 57 (9): 1123–1131. https://doi.org/10.1177/0284185115617346.Vincens E., Balleyguier C., Rey A., Uzan C., Zareski E., Gouy S., Pautier P., Duvillard P., Haie-Meder C., Morice P. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy: correlation of radiologic findings with surgicopathologic results. Cancer. 2008; 113 (8): 2158–2165. https://doi.org/10.1002/cncr.23817.Vincens E., Balleyguier C., Rey A., Uzan C., Zareski E., Gouy S., Pautier P., Duvillard P., Haie-Meder C., Morice P. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy: correlation of radiologic findings with surgicopathologic results. Cancer. 2008; 113 (8): 2158–2165. https://doi.org/10.1002/cncr.23817.Hameeduddin A., Sahdev A. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies Cancer Imaging. 2015; 15 (1): 3. https://doi.org/10.1186/s40644-015-0037-1.Hameeduddin A., Sahdev A. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies Cancer Imaging. 2015; 15 (1): 3. https://doi.org/10.1186/s40644-015-0037-1.Kuang F., Ren J., Zhong Q., Liyuan F., Huan Y., Chen Z. The value of apparent diffusion coefficient in the assessment of cervical cancer. Eur. Radiol. 2013; 23: 1050–1058. https://doi.org/10.1007/s00330-012-2681-1.Kuang F., Ren J., Zhong Q., Liyuan F., Huan Y., Chen Z. The value of apparent diffusion coefficient in the assessment of cervical cancer. Eur. Radiol. 2013; 23: 1050–1058. https://doi.org/10.1007/s00330-012-2681-1.Lucas R., Dias J.L., Cunha T.M. Added value of diffusionweighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrastenhanced MRI sequences Diagn. Interv. Radiol. 2015; 21 (5): 368–375. https://doi.org/10.5152/dir.2015.14427.Lucas R., Dias J.L., Cunha T.M. Added value of diffusionweighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrastenhanced MRI sequences Diagn. Interv. Radiol. 2015; 21 (5): 368–375. https://doi.org/10.5152/dir.2015.14427.Mayr N.A., Yuh W.T.C., Jajoura D., Wang J.Z., Lo S.S., Montebello J.F., Porter K., Zhang D., McMeekin D.S., Buatti J.M. Ultra-early Predictive Assay for Treatment Failure Using Functional Magnetic Resonance Imaging and Clinical Prognostic Parameters in Cervical Cancer. Cancer. 2010; 116 (4): 903–912. https://doi.org/10.1002/cncr.24822.Mayr N.A., Yuh W.T.C., Jajoura D., Wang J.Z., Lo S.S., Montebello J.F., Porter K., Zhang D., McMeekin D.S., Buatti J.M. Ultra-early Predictive Assay for Treatment Failure Using Functional Magnetic Resonance Imaging and Clinical Prognostic Parameters in Cervical Cancer. Cancer. 2010; 116 (4): 903–912. https://doi.org/10.1002/cncr.24822.

The authors declare that there are no conflicts of interest present.